US-based DuPont Industrial Biosciences has secured a grant from the European Commission (EC) to demonstrate high-efficiency enzyme production that would help increase biogas generation.
The demonstration will be part of the development of a European multimodel ensemble system for seasonal to interannual prediction (DEMETER) project, which is funded by the Bio Based Industries Joint Undertaking under the European Union’s (EU) Horizon 2020 Research and Innovation programme.
The enzyme technology is used to enhance biogas production and process robustness, helping in increasing revenue and profitability of customers, while providing more offerings in renewable energy.
Expected to be complete over the next three years, the DEMETER project will demonstrate an increase in production, as well as a reduction in cost during the production process of biogas enzymes, which can better the economics of biogas yield across Europe.
DuPont global marketing director Conrad Burke said: “DuPont is proud to be a partner in project DEMETER and to apply our decades of experience in the global industrial enzyme business to supporting the continued growth of the biogas sector in the EU and around the world.
“Ultimately, this project will demonstrate to biomethane producers the power of enzymes to improve biogas yields and process robustness, ultimately increasing their revenue and profitability.”
The grant received by DuPont will be used to upgrade and scale-up the enzyme-producing fermentation process in order to reduce cost by at least 15%.
The grant will also allow the company to demonstrate the efficiency of the enzymes in biogas field trials across Europe.
Methane biogas is mainly used to produce electricity or is compressed and inserted into the pipeline gas grid.
Recently, the company has created a new enzyme product that has been derived from Myceliophthora thermophila C1, and can reduce 10% in the cost of producing biogas from organic waste.
DuPont Industrial Biosciences combines agriculture, chemistry, biotechnology and material science capabilities to offer biobased solutions that would help address the requirements of an increasing population, along with protecting the environment for future generations.